NASDAQ · Financial Statements

DCGO (DCGO) Financial Statements

$0.40 NASDAQ: DCGO Market Cap $39.65M

DCGO most recently reported annual revenue of $322.0M, net profit of $-182.0M, revenue has compounded at 27.9% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$319.0M$441.0M$624.0M$617.0M$322.0M
Operating Profit$15.0M$22.0M$15.0M$29.0M$-89.0M
Net Profit$24.0M$35.0M$7.0M$20.0M$-182.0M
EPS$0.25$0.34$0.06$0.18$-1.84
Op Margin4.8%5.0%2.4%4.7%-27.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$310.0M$393.0M$490.0M$456.0M$217.0M
Total Liabilities$83.0M$114.0M$185.0M$140.0M$91.0M
Cash$176.0M$157.0M$59.0M$89.0M$51.0M
Borrowings$17.0M$20.0M$46.0M$57.0M$29.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$29.0M$-64.0M$70.0M$34.0M
Investing Cash Flow$-15.0M$-44.0M$-40.0M$-17.0M$-47.0M
Financing Cash Flow$-20.0M$-2.0M$-21.0M$1.29T$-16.0M
Net Cash Flow$145.0M$-15.0M$-92.0M$35.0M$-55.0M
Free Cash Flow$-9.0M$23.0M$-74.0M$65.0M$27.0M

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
DCGO Overview DCGO Dividend Run Stock Screener